Track topics on Twitter Track topics that are important to you
Abivax has unveiled new data that may suggest its clinical candidate ABX464 could be a safe, functional cure for human...Read More... The post Abivax believes it has made progress towards HIV cure app...
Abivax has completed dosing patients in the ABX464-101 trial, a Phase lla clinical trial investigating the safety and efficacy of...Read More... The post Abivax completes dosing in ABX464-101 trial fo...
Abivax CEO outlines next moves after Phase IIa trial using ABX464 showed first proof in human of viral load reduction...
Abivax has reported positive topline results from its Phase lla ABX464-101 clinical trial evaluating the safety and efficacy of ABX464...Read More... The post Abivax reports positive topline results f...
Abivax Phase IIa data for its lead asset showed impressive results in ulcerative colitis. The biotech's CEO tells Scrip trials...
ABIVAX schließt Patientenrekrutierung für klinische Phase-2a-Studie mit ABX464 zur Behandlung von Patienten mit Colitis ulcerosa ab DGAP-News: ABIVAX / Schlagwort(e): Studie ABIVAX schließt Patien....
ABIVAX ernennt Ian McGowan zum Vorsitzenden und Jürgen Rockstroh zum neuen Mitglied seines wissenschaftlichen Beirats DGAP-News: ABIVAX / Schlagwort(e): Personalie ABIVAX ernennt Ian McGowan zum V...
French biotech moves on with the late stage drug development, after publishing impressive clinical trial results of ABX464 for treatment of colitis and hinting its potential in Crohn’s disease. Ab...
We have published hundreds of ABIVAX news stories on BioPortfolio along with dozens of ABIVAX Clinical Trials and PubMed Articles about ABIVAX for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of ABIVAX Companies in our database. You can also find out about relevant ABIVAX Drugs and Medications on this site too.